Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromodomain Y-linked 22 pseudogene (CDY22P)
- Target
- CDY22P
- Molecular classification
- Pseudogene, Chromodomain protein family (by homology to parent gene)
01
Overview
Chromodomain Y-linked 22 pseudogene (CDY22P) is a duplicated pseudogene on human chromosome 22, derived from the family of chromodomain Y-linked (CDY) genes present on the Y chromosome[1]. Pseudogenes are traditionally classified as nonfunctional genomic relics but are now recognized to sometimes produce noncoding RNAs with regulatory activity in specific genetic or disease contexts[4][6]. While some chromosome 22 pseudogenes show transcriptional activity, strong evidence for functional protein product or clinical relevance for CDY22P does not exist[1]. No therapeutic drugs target this pseudogene, and it is not considered a receptor, enzyme, transporter, or other classical drug target. The main relevance of the region is for research into genome structure, pseudogene evolution, and rare regulatory phenomena.
- Other names
- CDY22P
02
Biological functions
No known protein-coding functionPossible transcription as noncoding RNARegulatory interference (microRNA decoy, competitive endogenous RNA), based on general pseudogene activity
03
Disease associations
None specific for CDY22PGene regulation through RNA-mediated processes (by analogy with other pseudogenes)Rare associations with chromosome rearrangements or local effects, but not established for CDY22P
Beyond the preview
Go deeper on Chromodomain Y-linked 22 pseudogene (CDY22P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chromodomain Y-linked 22 pseudogene (CDY22P).